Skip to main content
All lobbying filings

RED+BLUE STRATEGIES

Lobbying for GENEDX, LLC · Health Care Diagnostics

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Connecticut · House · Senate · $80,000.00 income · posted Jul 17, 2026

Official filing document

 Bills named in this filing 4
 Lobbying activity 2
Health Issues

H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.

Medicare/Medicaid

Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem